PTK2 and acute myeloid leukemia: In-vivo studies demonstrated that circ-PTK2 bound and sequestered miR-330-5p, leading to increased expression of FOXM1. High expression of circ-PTK2 was associated with shorter survival in AML patients, presumably due to its effect on leukemic cell proliferation and apoptosis.